Caricamento...
Immunoreactivity of anti-gelsolin antibodies: implications for biomarker validation
BACKGROUND: Proteomic-based discovery of biomarkers for disease has recently come under scrutiny for a variety of issues; one prominent issue is the lack of orthogonal validation for biomarkers following discovery. Validation by ELISA or Western blot requires the use of antibodies, which for many po...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2010
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3019187/ https://ncbi.nlm.nih.gov/pubmed/21171974 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-8-137 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|